XML 34 R20.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT INFORMATION
 9 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
SEGMENT INFORMATION

 

(12)SEGMENT INFORMATION

 

The Company views its operations and manages its business in one operating segment: life science. The table below summarizes the significant expense categories for the life science segment regularly provided to the Company’s Chief Financial Officer/Chief Operating Officer (the “CFO/COO”), its Chief Operating Decision Maker (the “CODM”).

 

 

PALATIN TECHNOLOGIES, INC.

and Subsidiary

 

Notes to Consolidated Financial Statements

 

The accounting policies of the Company’s segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for its segment based on net loss, which is reported on the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total assets. The CODM uses cash forecast models in deciding how to invest into the segment. The CODM analyzes the Company’s net loss and monitors budget versus actual results to assess the performance of the Company.

 

   2026   2025   2026   2025 
   Three Months Ended March 31,   Nine Months Ended March 31, 
   2026   2025   2026   2025 
Total Revenues  $3,920,675   $-   $12,884,261   $- 
Less:                    
Program spend   2,012,143    1,853,851    5,272,845    7,822,953 
Personnel costs   2,599,878    2,498,518    7,894,707    6,936,700 
Administrative costs (a)   889,648    876,808    3,965,198    3,345,532 
Gain on Sale of Vyleesi   -    -    -    (2,500,000)
Gain on Purchase Commitment   -    (416,000)   -    (416,000)
Other segment items (b)   (148,007)   (1,757)   (229,175)   (111,634)
Segment net loss  $(1,432,987)  $(4,811,420)  $(4,019,314)  $(15,077,551)

 

(a)Contains depreciation and amortization. Depreciation was $16,952 and $45,727 for the three and nine months ended March 31, 2026, respectively, compared to $53,304 and $205,924 for the three and nine months ended March 31, 2025, respectively.
(b)Other segment items include investment income, interest expense and foreign currency (gain)loss, which are disclosed in the consolidated financial statements.